Selective Reoperation for Locally Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma Following Primary Pancreatic Resection

被引：0
|
作者：
Ryan M. Thomas
Mark J. Truty
Graciela M. Nogueras-Gonzalez
Jason B. Fleming
Jean-Nicolas Vauthey
Peter W. T. Pisters
Jeffrey E. Lee
David C. Rice
Wayne L. Hofstetter
Robert A. Wolff
Gauri R. Varadhachary
Huamin Wang
Matthew H. G. Katz
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Surgical Oncology, Unit 444
[2] The University of Texas MD Anderson Cancer Center,Department of Biostatistics
[3] The University of Texas MD Anderson Cancer Center,Department of Thoracic and Cardiovascular Surgery
[4] The University of Texas MD Anderson Cancer Center,Department of Gastrointestinal Medical Oncology
[5] The University of Texas MD Anderson Cancer Center,Department of Pathology
来源：
Journal of Gastrointestinal Surgery | 2012年 / 16卷
关键词：
Pancreatic ductal adenocarcinoma; Metastasectomy; Reoperation; Locoregional recurrence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1696 / 1704
页数：8
相关论文
共 50 条
  • [41] Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection
    Flis, Vojko
    Potrc, Stojan
    Kobilica, Nina
    Ivanecz, Arpad
    RADIOLOGY AND ONCOLOGY, 2016, 50 (03) : 321 - 328
  • [42] Benefit of venous resection for ductal adenocarcinoma of the pancreatic head
    Hartel, M
    Niedergethmann, M
    Farag-Soliman, M
    Sturm, JW
    Richter, A
    Trede, M
    Post, S
    EUROPEAN JOURNAL OF SURGERY, 2002, 168 (12) : 707 - 712
  • [43] Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma
    Michael E Feigin
    Tyler Garvin
    Peter Bailey
    Nicola Waddell
    David K Chang
    David R Kelley
    Shimin Shuai
    Steven Gallinger
    John D McPherson
    Sean M Grimmond
    Ekta Khurana
    Lincoln D Stein
    Andrew V Biankin
    Michael C Schatz
    David A Tuveson
    Nature Genetics, 2017, 49 : 825 - 833
  • [44] TGF- Inhibitors in Metastatic Pancreatic Ductal Adenocarcinoma
    Alvarez, Marcus A.
    Freitas, Julia Pedo
    Hussain, S. Mazher
    Glazer, Evan S.
    JOURNAL OF GASTROINTESTINAL CANCER, 2019, 50 (02) : 207 - 213
  • [45] New Treatment Strategies for Metastatic Pancreatic Ductal Adenocarcinoma
    Ritu Raj Singh
    Eileen M. O’Reilly
    Drugs, 2020, 80 : 647 - 669
  • [46] Applied precision medicine in metastatic pancreatic ductal adenocarcinoma
    Taghizadeh, Hossein
    Muellauer, Leonhard
    Mader, Robert M.
    Schindl, Martin
    Prager, Gerald W.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [47] Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma
    Feigin, Michael E.
    Garvin, Tyler
    Bailey, Peter
    Waddell, Nicola
    Chang, David K.
    Shuai, Shimin
    Gallinger, Steven
    McPherson, John D.
    Grimmond, Sean M.
    Khurana, Ekta
    Stein, Lincoln D.
    Biankin, Andrew V.
    Schatz, Michael C.
    Tuveson, David A.
    CANCER RESEARCH, 2016, 76
  • [48] TGF-β Inhibitors in Metastatic Pancreatic Ductal Adenocarcinoma
    Marcus A. Alvarez
    Júlia Pedó Freitas
    S. Mazher Hussain
    Evan S. Glazer
    Journal of Gastrointestinal Cancer, 2019, 50 : 207 - 213
  • [49] Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma
    Feigin, Michael E.
    Garvin, Tyler
    Bailey, Peter
    Waddell, Nicola
    Chang, David K.
    Kelley, David R.
    Shuai, Shimin
    Gallinger, Steven
    McPherson, John D.
    Grimmond, Sean M.
    Khurana, Ekta
    Stein, Lincoln D.
    Biankin, Andrew V.
    Schatz, Michael C.
    Tuveson, David A.
    NATURE GENETICS, 2017, 49 (06) : 825 - +
  • [50] New Treatment Strategies for Metastatic Pancreatic Ductal Adenocarcinoma
    Singh, Ritu Raj
    O'Reilly, Eileen M.
    DRUGS, 2020, 80 (07) : 647 - 669
12345